News

A new research project aimed at finding a cure for the genetic disorder Neurofibromatosis (NF) has received $350,000 in funding from the Flicker of Hope Foundation delivered through the Sydney Children’s Hospitals Foundation.

At four months of age Sophia is reaching all her developmental milestones. She demonstrates good head control while sitting supported and can even roll from her tummy to her back.

New study found fenfluramine was an effective and safe treatment for Dravet Syndrome, reducing the number of epileptic seizures by over 75 per cent. For Bronte, this meant she went from having 10 seizures a day to just one or two a week and even began having seizure free weeks.

The first ever clinical practice guidelines for children with Charcot-Marie-Tooth disease (CMT) have been published after a decade of work by an international team.

The benefits of a new precision medicine initiative, being piloted at Sydney Children’s Hospitals Network (SCHN), are already being seen in children and families with rare genetic diseases.